Apotex prices C$1.3 billion IPO at top of range
The Canadian health company priced its upsized initial public offering at C$24 per share and sold 54.17 million common shares. Apotex expects to begin trading on the Toronto Stock Exchange this Wednesday under the ticker symbol APTX.
Insights:
Apotex Health priced its upsized initial public offering at the C$24 top end on Tuesday, June 9, raising C$1.3 billion in gross proceeds. The healthcare provider in Canada sold 54.17 million common shares after increasing the offering size to meet investor demand. The pricing at the peak of the range suggests a robust appetite for pharmaceutical listings as the firm prepares for its public debut.
